Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71476 - 71500 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	LOXL2	4017	upregulated	Silicon Dioxide analog results in increased expression of LOXL2 mRNA	8p21.3	A24195
Silicon dioxide	Approved	LOXL3	84695	upregulated	Silicon Dioxide analog results in increased expression of LOXL3 mRNA	2p13.1	A24195
Silicon dioxide	Approved	LOXL4	84171	downregulated	Silicon Dioxide analog results in decreased expression of LOXL4 mRNA	10q24.2	A24195
Silicon dioxide	Approved	LPAL2	80350	downregulated	Silicon Dioxide analog results in decreased expression of LPAL2 mRNA	6q25.3	A24195
Silicon dioxide	Approved	LPAR5	57121	downregulated	Silicon Dioxide analog results in decreased expression of LPAR5 mRNA	12p13.31	A24195
Silicon dioxide	Approved	LPAR6	10161	downregulated	Silicon Dioxide analog results in decreased expression of LPAR6 mRNA	13q14.2	A24195
Silicon dioxide	Approved	LPCAT2	54947	downregulated	Silicon Dioxide analog results in decreased expression of LPCAT2 mRNA	16q12.2	A24195
Silicon dioxide	Approved	LPCAT3	10162	upregulated	Silicon Dioxide results in increased expression of LPCAT3 mRNA	12p13.31	A24196
Silicon dioxide	Approved	LPIN2	9663	upregulated	Silicon Dioxide analog results in increased expression of LPIN2 mRNA	18p11.31	A24194
Silicon dioxide	Approved	LRAT	9227	downregulated	Silicon Dioxide results in decreased expression of LRAT mRNA	4q32.1	A24196
Silicon dioxide	Approved	LRCH1	23143	upregulated	Silicon Dioxide analog results in increased expression of LRCH1 mRNA	13q14.13-q14.2	A24195
Silicon dioxide	Approved	LRCH2	57631	upregulated	Silicon Dioxide analog results in increased expression of LRCH2 mRNA	Xq23	A24194
Silicon dioxide	Approved	LRCH3	84859	upregulated	Silicon Dioxide analog results in increased expression of LRCH3 mRNA	3q29	A24194
Silicon dioxide	Approved	LRCOL1	100507055	upregulated	Silicon Dioxide analog results in increased expression of LRCOL1 mRNA	12q24.33	A24195
Silicon dioxide	Approved	LRFN5	145581	upregulated	Silicon Dioxide analog results in increased expression of LRFN5 mRNA	14q21.1	A24195
Silicon dioxide	Approved	LRG1	116844	downregulated	Silicon Dioxide analog results in decreased expression of LRG1 mRNA	19p13.3	A24195
Silicon dioxide	Approved	LRGUK	136332	downregulated	Silicon Dioxide analog results in decreased expression of LRGUK mRNA	7q33	A24195
Silicon dioxide	Approved	LRIF1	55791	upregulated	Silicon Dioxide analog results in increased expression of LRIF1 mRNA	1p13.3	A24195
Silicon dioxide	Approved	LRIG1	26018	downregulated	Silicon Dioxide analog results in decreased expression of LRIG1 mRNA	3p14.1	A24195
Silicon dioxide	Approved	LRMP	4033	downregulated	Silicon Dioxide results in decreased expression of LRMP mRNA	12p12.1	A24196
Silicon dioxide	Approved	LRP10	26020	downregulated	Silicon Dioxide analog results in decreased expression of LRP10 mRNA	14q11.2	A24195
Silicon dioxide	Approved	LRP11	84918	downregulated	Silicon Dioxide analog results in decreased expression of LRP11 mRNA	6q25.1	A24195
Silicon dioxide	Approved	LRRC17	10234	downregulated	Silicon Dioxide results in decreased expression of LRRC17 mRNA	7q22.1	A24197
Silicon dioxide	Approved	LRRC19	64922	downregulated	Silicon Dioxide analog results in decreased expression of LRRC19 mRNA	9p21.2	A24195
Silicon dioxide	Approved	LRRC2	79442	upregulated	Silicon Dioxide analog results in increased expression of LRRC2 mRNA	3p21.31	A24195

Displaying entries 71476 - 71500 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability